Senores Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has informed the NSE that the trading window for its designated persons (insiders) is closed, in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015. This is a standard regulatory filing that typically precedes a material corporate announcement such as financial results, board meeting outcomes, or an AGM. The company has not disclosed the specific reason or the reopening date in this filing. Such closures are mandatory to prevent insiders from trading on unpublished price-sensitive information.
No direct impact on retail shareholders or stock price. This is a routine compliance measure signalling that a corporate announcement is likely forthcoming once the window reopens.